
Our mission
We strive to discover and develop truly effective therapeutics for neurodegenerative diseases.

Our Team
We are a passionate team of scientists and drug developers dedicated to improving the lives of patients affected by neurodegenerative diseases.

Our R&D pipeline
Our pipeline of innovative small molecules has the potential to halt and prevent neurodegeneration in certain brain diseases.
Asceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs:
orphan tauopathies, Alzheimer’s and Parkinson’s diseases.